Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER SR DAKHIL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1972721348
CMS profile
44029
Location
WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$18,215.72

191 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 191 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER SR DAKHIL

NPI 1972721348 · CMS profile ID 44029

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 191 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972721348?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER SR DAKHIL, NPI 1972721348, CMS profile ID 44029. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 191 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972721348?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). CHRISTOPHER SR DAKHIL, NPI 1972721348, CMS profile ID 44029. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 191 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972721348?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
CHRISTOPHER SR DAKHIL, NPI 1972721348, CMS profile ID 44029, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 191 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1972721348?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

191 matching records · $18,215.72 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 191 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 191.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SOBI, INC $77.9909/06/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038126489 CMS
Daiichi Sankyo Inc. $832.5009/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006613443 CMS
Incyte Corporation $24.8408/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044695129 CMS
Janssen Biotech, Inc. $14.6408/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988391515 CMS
Daiichi Sankyo Inc. $22.2308/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006473736 CMS
AVEO Pharmaceuticals, Inc. $18.7908/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049057495 CMS
Celgene Corporation $16.6008/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630077 CMS
GlaxoSmithKline, LLC. $17.5408/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001877397 CMS
PFIZER INC. $13.1908/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050688307 CMS
E.R. Squibb & Sons, L.L.C. $15.3508/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630051 CMS
Pharmacyclics LLC, An AbbVie Company $17.3208/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998284119 CMS
GENZYME CORPORATION $11.4608/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050099551 CMS
Octapharma USA, Inc. $12.7908/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042720499 CMS
Sun Pharmaceutical Industries Inc. $15.9208/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053818887 CMS
Genentech USA, Inc. $14.7508/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040330831 CMS
Merck Sharp & Dohme LLC $22.0808/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048643437 CMS
GENZYME CORPORATION $17.1408/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050099545 CMS
Gilead Sciences, Inc. $13.0608/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026044233 CMS
Eisai Inc. $22.2008/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023305751 CMS
Celgene Corporation $8.3308/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630047 CMS
Daiichi Sankyo Inc. $1,387.5008/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006611867 CMS
PFIZER INC. $15.6408/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050468793 CMS
AVEO Pharmaceuticals, Inc. $14.9307/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049057499 CMS
Novartis Pharmaceuticals Corporation $15.1807/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991712281 CMS
PFIZER INC. $13.3507/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050555753 CMS
PFIZER INC. $0.3607/27/2023 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228763140 CMS
E.R. Squibb & Sons, L.L.C. $4.4207/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630027 CMS
Celgene Corporation $11.9007/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630063 CMS
SOBI, INC $14.3707/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038111947 CMS
Seagen Inc. $15.5807/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995733567 CMS
GENZYME CORPORATION $17.8007/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050099517 CMS
Seagen Inc. $9.7407/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995733543 CMS
PFIZER INC. $11.4407/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049353681 CMS
PFIZER INC. $6.1707/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049513643 CMS
Merck Sharp & Dohme LLC $14.2907/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048638021 CMS
Celgene Corporation $11.6407/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630007 CMS
GENZYME CORPORATION $17.6607/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050099548 CMS
Janssen Biotech, Inc. $10.5906/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988391561 CMS
Celgene Corporation $18.9406/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630020 CMS
Gilead Sciences, Inc. $3.5906/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026146415 CMS
Genmab U.S., Inc. $15.6406/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343497 CMS
Celgene Corporation $5.7006/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015630043 CMS
Incyte Corporation $13.6406/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044695015 CMS
GlaxoSmithKline, LLC. $17.3406/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001880213 CMS
Daiichi Sankyo Inc. $2,775.0006/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006608875 CMS
Astellas Pharma US Inc $15.4506/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034162391 CMS
Merck Sharp & Dohme LLC $13.7906/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048838671 CMS
GENZYME CORPORATION $15.2806/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050099509 CMS
Janssen Biotech, Inc. $28.9606/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988391579 CMS
Janssen Biotech, Inc. $14.7606/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988391601 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,186.95 149
PY2020 $6,168.70 101
PY2021 $6,404.97 141
PY2022 $13,209.82 175
PY2023 $18,215.72 191
PY2024 $4,814.36 190
PY2025 $4,078.06 166

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Recipient $1,536.87 1
PY2022 Principal investigator $15,607.00 5
PY2021 Principal investigator $4,600.00 1
PY2019 Principal investigator $34,271.25 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $3,500.00 09/19/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDOCRINE THERAPY VS ANTIHER2 THERAPY ENDOCRINE THERAPY AFTER INDUCTION TREATMENT FOR HRHER2 METASTATIC BREAST CANCER No dispute reported 06/30/2026 949757193
Principal investigator 1 PFIZER INC. $1,275.00 08/22/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDOCRINE THERAPY VS ANTIHER2 THERAPY ENDOCRINE THERAPY AFTER INDUCTION TREATMENT FOR HRHER2 METASTATIC BREAST CANCER No dispute reported 06/30/2026 949757135
Principal investigator 1 PFIZER INC. $1,275.00 08/22/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDOCRINE THERAPY VS ANTIHER2 THERAPY ENDOCRINE THERAPY AFTER INDUCTION TREATMENT FOR HRHER2 METASTATIC BREAST CANCER No dispute reported 06/30/2026 949757137
Principal investigator 1 PFIZER INC. $2,477.00 06/21/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
A PHASE 2 STUDY OF CONTINUOUS TALAZOPARIB PLUS INTERMITTENT LOWDOSE TEMOZOLOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY EXTENSIVESTAGE SMALL CELL LUNG CANCER TRIOUS L07 No dispute reported 06/30/2026 949805437
Recipient F. Hoffmann-La Roche AG $1,536.87 03/31/2022 Covered Recipient Physician A PHASE II SINGLE-ARM STUDY OF ATEZOLIZUMAB MONOTHERAPY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER CLINICAL EVALUATION OF NOVEL BLOOD-BASED DIAGNOSTICS No dispute reported 06/30/2026 950635685
Principal investigator 1 PFIZER INC. $7,080.00 02/01/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
A PHASE 2 STUDY OF CONTINUOUS TALAZOPARIB PLUS INTERMITTENT LOWDOSE TEMOZOLOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY EXTENSIVESTAGE SMALL CELL LUNG CANCER TRIOUS L07 No dispute reported 06/30/2026 949804953